Corrigendum to “A novel flavonoid isolated from the steam-bark of Ulmus wallichiana planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation” [Eur. J. Pharmacol. 658(2–3) 2011 65–73] (S0014299911002172) (10.1016/j.ejphar.2011.02.032));A novel flavonoid isolated from the steam-bark of Ulmus Wallichiana Planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation

European Journal of Pharmacology

Volumn 658, Issue 2-3, 2011, Pages 65-73

  Swarnkar, Gaurav ^a   Sharan, Kunal ^a   Siddiqui, Jawed A ^a   Chakravarti, Bandana ^a   Rawat, Preeti ^a   Kumar, Manmeet ^a   Arya, Kamal R ^a   Maurya, Rakesh ^a   Chattopadhyay, Naibedya ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Adipogenesis; Bone marrow; Flavonoid C glucoside; Osteoclastogenesis; Osteogenic

Indexed keywords

AROMADENDRIN 6 BETA DEXTRO GLUCOPYRANOSIDE; BONE MORPHOGENETIC PROTEIN 2; CCAAT ENHANCER BINDING PROTEIN ALPHA; COLLAGEN TYPE 1; COLONY STIMULATING FACTOR 1; FLAVONOID; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; BARK; BONE MARROW CELL; BONE MINERALIZATION; CALVARIA; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROTECTION; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ELM; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; OSTEOCLAST ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULMUS WALLICHIANA; UPREGULATION;

EID: 79953796467     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2018.05.018     Document Type: Erratum

References (59)

1. Bandyopadhyay, S., Lion, J.M., Mentaverri, R., Ricupero, D.A., Kamel, S., Romero, J.R., Chattopadhyay, N., 2006. Attenuation of osteoclastogenesis and osteoclast function by apigenin. Biochem. Pharmacol. 72, 184-197.
2. Bhargavan, B., Gautam, A.K., Singh, D., Kumar, A., Chaurasia, S., Tyagi, A.M., Yadav, D.K., Mishra, J.S., Singh, A.B., Sanyal, S., Goel, A., Maurya, R., Chattopadhyay, N., 2009. Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differentialmitogen activated proteinkinase (MAPK) signaling. J.Cell. Biochem. 108, 388-399.
3. Burkhardt, R., Kettner, G., Bohm, W., Schmidmeier, M., Schlag, R., Frisch, B., Mallmann, B., Eisenmenger, W., Gilg, T., 1987. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 8, 157-164. (Pubitemid 17111858)
4. Christiansen, T., Richelsen, B., Bruun, J.M., 2005. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int. J. Obes. (Lond) 29, 146-150.
5. Cirmanova, V., Bayer, M., Starka, L., Zajickova, K., 2008. The effect of leptin on bone: an evolving concept of action. Physiol. Res. 57 (Suppl 1), S143-S151.
6. Ebina, K., Fukuhara, A., Shimomura, I., 2008. Role of adipocytokine in bone metabolism. Clin. Calcium 18, 623-630.
7. Fernandez-Garcia, D., Munoz-Torres, M., Mezquita-Raya, P., de la Higuera, M., Alonso, G., Reyes-Garcia, R., Ochoa, A.S., Ruiz-Requena, M.E., Luna, J.D., Escobar-Jimenez, F., 2008. Effects of raloxifene therapy on circulating osteoprotegerin and RANK ligand levels in post-menopausal osteoporosis. J. Endocrinol. Investig. 31, 416-421.
8. Franceschi, R.T., 1999. The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit. Rev. Oral Biol. Med. 10, 40-57.
9. Gautam, A.K., Bhargavan, B., Tyagi, A.M., Srivastava, K., Yadav, D.K., Kumar, M., Singh, A., Mishra, J.S., Singh, A.B., Sanyal, S., Maurya, R., Manickavasagam, L., Singh, S.P., Wahajuddin, W., Jain, G.K., Chattopadhyay, N., Singh, D., 2011. Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats. J. Nutr. Biochem. 22, 318-327.
10. Giner, M., Rios, M.A., Montoya, M.A., Vazquez, M.A., Naji, L., Perez-Cano, R., 2009. RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis. J. Steroid Biochem. Mol. Biol. 113, 46-51.
11. Gregory, C.A., Gunn, W.G., Peister, A., Prockop, D.J., 2004. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal. Biochem. 329, 77-84.
12. Heim, M., Johnson, J., Boess, F., Bendik, I., Weber, P., Hunziker, W., Fluhmann, B., 2002. Phytanic acid, a natural peroxisome proliferator-activated receptor (PPAR) agonist, regulates glucose metabolism in rat primary hepatocytes. FASEB J. 16, 718-720.
13. Holinka, C.F., Hata, H., Kuramoto, H., Gurpide, E., 1986. Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line). Cancer Res. 46, 2771-2774. (Pubitemid 16074279)
14. Horcajada-Molteni, M.N., Crespy, V., Coxam, V., Davicco, M.J., Remesy, C., Barlet, J.P., 2000. Rutin inhibits ovariectomy-induced osteopenia in rats. J. Bone Miner. Res. 15, 2251-2258.
15. Ishikawa, T., Kamiyama, M., Tani-Ishii, N., Suzuki, H., Ichikawa, Y., Hamaguchi, Y., Momiyama, N., Shimada, H., 2001. Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides. Mol. Carcinog. 32, 84-91.
16. Kamo, K., Miyakoshi, N., Kasukawa, Y., Nozaka, K., Sasaki, H., Shimada, Y., 2010. Intermittent weekly administration of human parathyroid hormone (1-34) improves bone-hydroxyapatite block bonding in ovariectomized rats. J. Bone Miner. Met. 6, 634-640.
17. Kawai, M., Devlin, M.J., Rosen, C.J., 2009. Fat targets for skeletal health. Nat. Rev. Rheumatol. 5, 365-372.
18. Khosla, S., 2001. Minireview: the OPG/RANKL/RANK system. Endocrinology 142, 5050-5055. (Pubitemid 33131929)
19. King, G.A., Deemer, S.E., Thompson, D.L., 2010. Relationship between leptin, adiponectin, bone mineral density, and measures of adiposity among pre-menopausal Hispanic and Caucasian women. Endocr. Res. 35, 106-117.
20. Komrakova, M., Stuermer, E.K., Werner, C., Wicke, M., Kolios, L., Sehmisch, S., Tezval, M., Daub, F., Martens, T., Witzenhausen, P., Dullin, C., Stuermer, K.M., 2010. Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone 47, 480-492.
21. Lafage-Proust, M.H., Thomas, T., Guignandon, A., Malaval, L., Rattner, A., Vico, L., 2007. Plasticity of osteoprogenitor cells. Joint Bone Spine 74, 536-539. (Pubitemid 350245622)
22. Laharrague, P., Truel, N., Fontanilles, A.M., Corberand, J.X., Penicaud, L., Casteilla, L., 2000. Regulation by cytokines of leptin expression in human bone marrow adipocytes. Horm. Metab. Res. 32, 381-385.
23. Lee, M.W., 1994. Determination of the structure for polysubstituted flavonoid and 6-C-glucosyl flavonoids using 13C-1H long range couplings. Arch. Pharm. Res. 17, 487-489.
24. Lewiecki, E.M., 2010a. Denosumab - an emerging treatment for postmenopausal osteoporosis. Expert Opin. Biol. Ther. 10, 467-476.
25. Lewiecki, E.M., 2010b. Treatment of osteoporosis with denosumab. Maturitas 66, 182-186.
26. Lin, J., Della-Fera, M.A., Baile, C.A., 2005. Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obes. Res. 13, 982-990.
27. Littlefield, B.A., Gurpide, E., Markiewicz, L., McKinley, B., Hochberg, R.B., 1990. A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in Ishikawa cells: estrogenic action of delta 5 adrenal steroids. Endocrinology 127, 2757-2762.
28. Maniatopoulos, C., Sodek, J., Melcher, A.H., 1988. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res. 254, 317-330.
29. Manolagas, S.C., Kousteni, S., Jilka, R.L., 2002. Sex steroids and bone. Recent Prog. Horm. Res. 57, 385-409.
30. Maurya, R., Yadav, D.K., Singh, G., Bhargavan, B., Narayana Murthy, P.S., Sahai, M., Singh, M.M., 2009. Osteogenic activity of constituents from Butea monosperma. Bioorg. Med. Chem. Lett. 19, 610-613.
31. Meunier, P., Aaron, J., Edouard, C., Vignon, G., 1971. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin. Orthop. Relat. Res. 80, 147-154.
32. Mok, S.K., Chen, W.F., Lai, W.P., Leung, P.C., Wang, X.L., Yao, X.S., Wong, M.S., 2010. Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br. J. Pharmacol. 159, 939-949.
33. Nozaka, K., Miyakoshi, N., Kasukawa, Y., Maekawa, S., Noguchi, H., Shimada, Y., 2008. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats. Bone 42, 90-97.
34. Oursler, M.J., 1998. Estrogen regulation of gene expression in osteoblasts and osteoclasts. Crit. Rev. Eukaryot. Gene Expr. 8, 125-140.
35. Pang, J.L., Ricupero, D.A., Huang, S., Fatma, N., Singh, D.P., Romero, J.R., Chattopadhyay, N., 2006. Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells. Biochem. Pharmacol. 71, 818-826.
36. Prasain, J.K., Barnes, S., 2007. Metabolism and bioavailability of flavonoids in chemoprevention: current analytical strategies and future prospectus. Mol. Pharm. 4, 846-864.
37. Prouillet, C., Maziere, J.C., Maziere, C., Wattel, A., Brazier, M., Kamel, S., 2004. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem. Pharmacol. 67, 1307-1313.
38. Raisz, L.G., Rodan, G.A., 2003. Pathogenesis of osteoporosis. Endocrinol. Metab. Clin. North Am. 32, 15-24.
39. Rawat, P., Kumar, M., Sharan, K., Chattopadhyay, N., Maurya, R., 2009. Ulmosides A and B: flavonoid 6-C-glycosides from Ulmus wallichiana, stimulating osteoblast differentiation assessed by alkaline phosphatase. Bioorg. Med. Chem. Lett. 19, 4684-4687.
40. Reid, I.R., 2008. Anti-resorptive therapies for osteoporosis. Semin. Cell Dev. Biol. 19, 473-478.
41. Sekiya, I., Larson, B.L., Vuoristo, J.T., Cui, J.G., Prockop, D.J., 2004. Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). J. Bone Miner. Res. 19, 256-264. (Pubitemid 38116739)
42. Setchell, K.D., Lydeking-Olsen, E., 2003. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am. J. Clin. Nutr. 78, 593S-609S.
43. Sharan, K., Siddiqui, J.A., Swarnkar, G., Maurya, R., Chattopadhyay, N., 2009. Role of phytochemicals in the prevention of menopausal bone loss: evidence from in vitro and in vivo, human interventional and pharma-cokinetic studies. Curr. Med. Chem. 16, 1138-1157.
44. Sharan, K., Siddiqui, J.A., Swarnkar, G., Tyagi, A.M., Kumar, A., Rawat, P., Kumar, M., Nagar, G.K., Arya, K.R., Manickavasagam, L., Jain, G.K., Maurya, R., Chattopadhyay, N., 2010a. Extract and fraction from Ulmus wallichiana Planchon promote peak bone achievement and have a nonestrogenic osteoprotective effect. Menopause 17, 393-402.
45. Sharan, K., Swarnkar, G., Siddiqui, J.A., Kumar, A., Rawat, P., Kumar, M., Nagar, G.K., Manickavasagam, L., Singh, S.P., Mishra, G., Wahajuddin, Jain, G.K., Maurya, R., Chattopadhyay, N., 2010b. A novel flavonoid, 6-C-beta-d-glucopyranosyl-(2S,3S)- (+)-3′,4′,5,7- tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon mitigates ovariectomy-induced osteoporosis in rats. Menopause 17, 577-586.
46. Siddiqui, J.A., Sharan, K., Swarnkar, G., Rawat, P., Kumar, M., Manickavasagam, L., Maurya, R., Pierroz, D., Chattopadhyay, N., 2011a. Quercetin-6-C-beta-d-glucopyranoside isolated from Ulmus wallichiana Planchon is more potent than quercetin in inhibiting osteoclastogenesis and mitigating ovariectomy-induced bone loss in rats. Menopause 2, 198-207.
47. Siddiqui, J.A., Swarnkar, G., Sharan, K., Chakravarti, B., Gautam, A.K., Rawat, P., Kumar, M., Gupta, V., Manickavasagam, L., Dwivedi, A.K., Maurya, R., Chattopadhyay, N., 2011b. A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone. Osteoporos. Int. doi:10.1007/s00198-010-1519-4.
48. Siddiqui, J.A., Swarnkar, G., Sharan, K., Chakravarti, B., Sharma, G., Rawat, P., Kumar, M., Khan, F.M., Pierroz, D., Maurya, R., Chattopadhyay, N., 2010. 8,8″-Biapigeninyl stimulates osteoblast functions and inhibits osteoclast and adipocyte functions: Osteoprotective action of 8,8″-biapigeninyl in ovariectomized mice. Mol Cell Endocrinol 323, 256-267.
49. Soltan, M., Smiler, D., Choi, J.H., 2009. Bone marrow: orchestrated cells, cytokines, and growth factors for bone regeneration. Implant Dent. 18, 132-141.
50. Tat, S.K., Pelletier, J.P., Velasco, C.R., Padrines, M., Martel-Pelletier, J., 2009. New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target? Keio J. Med. 58, 29-40.
51. Trivedi, R., Kumar, S., Kumar, A., Siddiqui, J.A., Swarnkar, G., Gupta, V., Kendurker, A., Dwivedi, A.K., Romero, J.R., Chattopadhyay, N., 2008. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats. Mol. Cell. Endocrinol. 289, 85-93.
52. Trivedi, R., Kumar, A., Gupta, V., Kumar, S., Nagar, G.K., Romero, J.R., Dwivedi, A.K., Chattopadhyay, N., 2009. Effects of Egb 761 on bone mineral density, bone microstructure, and osteoblast function: possible roles of quercetin and kaempferol. Mol. Cell. Endocrinol. 302, 86-91.
53. Trivedi, R., Mithal, A., Chattopadhyay, N., 2010. Anabolics in osteoporosis: the emerging therapeutic tool. Curr. Mol. Med. 10, 14-28.
54. Tyagi, A.M., Gautam, A.K., Kumar, A., Srivastava, K., Bhargavan, B., Trivedi, R., Saravanan, S., Yadav, D.K., Singh, N., Pollet, C., Brazier, M., Mentaverri, R., Maurya, R., Chattopadhyay, N., Goel, A., Singh, D., 2010. Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice. Mol. Cell. Endocrinol. 325, 101-109.
55. Verma, S., Rajaratnam, J.H., Denton, J., Hoyland, J.A., Byers, R.J., 2002. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J. Clin. Pathol. 55, 693-698.
56. Wasilewska, A., Rybi-Szuminska, A.A., Zoch-Zwierz, W., 2009. Serum osteoprotegrin (OPG) and receptor activator of nuclear factor kappaB (RANKL) in healthy children and adolescents. J. Pediatr. Endocrinol. Metab. 22, 1099-1104.
57. Wong, G.L., Kent, G.N., Ku, K.Y., Cohn, D.V., 1978. The interaction of parathormone and calcium on the hormone-regulated synthesis of hyaluronic acid and citrate decarboxylation in isolated bone cells. Endocrinology 103, 2274-2282. (Pubitemid 9075969)
58. Yue, J., Zhang, X., Dong, B., Yang, M., 2010. Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials. Menopause 5, 1701-1709.
59. Zallone, A., 2006. Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann. NY Acad. Sci. 1068, 173-179.